Treco James
SEC insider (Form 3/4/5 filer). CIK 0001766070. Director at Tonix Pharmaceuticals Holding Corp. (TNXP). 4 reported Form 4/5 transactions since Sep 2024; latest on May 12, 2026. Located in BERKELEY HEIGHTS, NJ.
Companies Treco James has filed insider reports for
- Tonix Pharmaceuticals Holding Corp. (TNXP): Director
Treco James
CIK: 0001766070
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tonix Pharmaceuticals Holding Corp.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 12, 2026TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
22.7K shares- - Aug 20, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
PurchaseDirect250 shares at avg. $36.00$9K - May 13, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
AwardDirectStock Option
10K shares- - Feb 5, 2025TNXP
Tonix Pharmaceuticals Holding Corp.
OtherDirect0 shares at avg. $0.30$0.006
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 12, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 22,700 | - | - | Direct |
| Aug 20, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Purchase | 250 | $36.00 | $9,000 | Direct |
| May 13, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Award Stock Option | 10,000 | - | - | Direct |
| Feb 5, 2025 | TNXP Tonix Pharmaceuticals Holding Corp. | Other | 0 | $0.30 | $0 | Direct |
1-4 of 4 transactions